Navigation Links
Neogen launches rapid tests for ractopamine

LANSING, Mich., March 21, 2013 /PRNewswire/ -- As international debate continues on the use of the feed additive ractopamine, Neogen Corporation (NASDAQ: NEOG) has launched easy 10 minute tests to detect ractopamine in animal and animal feed samples.

Ractopamine is a beta-agonist drug added to feed to promote lean muscle in animals raised for meat. While many countries allow the use of ractopamine within specified limits, including the United States, regulatory agencies in other countries have banned residues of the drug, including those in the European Union, Russia, and China.

"China recently followed Russia by imposing import restrictions on certain U.S. meat products, which require documentation that the products are free of ractopamine," said Ed Bradley , Neogen's vice president of Food Safety. "While top trade officials in the U.S. view the new restrictions as unnecessary trade barriers, markets in which ractopamine residues are banned are worth hundreds of millions of dollars annually to U.S. meat producers. Until these trade issues can be resolved, companies seeking access to these markets may have no choice but to comply with the new regulations." 

To ensure compliance with the new regulations, animal samples can be easily screened for the presence of ractopamine. In addition, feed manufacturers can use simple screening tests to verify the effectiveness of their cleanup procedures when switching production from ractopamine-medicated feed to feed intended to be ractopamine-free.  

Neogen's Ractopamine Lateral Flow Device (LFD) tests are intended to screen cattle and swine samples, and swine and turkey feed samples for the presence of ractopamine. The tests are one-step screening tests that easily detect the presence of ractopamine at set levels. The ractopamine screening test for swine screens at 2.5 parts per billion (ppb); the test for cattle screens at 1 ppb; and the test for swine and turkey feed screens at 0.5 or 4 parts per million.

The U.S. has set a maximum residue limit for ractopamine at 30 ppb for beef and 50 ppb for pork. The Codex Alimentarius, which creates international food guidelines, has a limit of 10 ppb for pork and beef.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division is a leader in the development of animal genomics along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care and disinfectants.

CONTACT: Bill Hoerner
Neogen Corporation, 517/372-9200


SOURCE Neogen Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Neogen Corporation Announces 3rd Quarter Results Conference Call
2. Neogen reports 30% increase in quarterly net income
3. Neogen Corporation Announces 1st Quarter Results Conference Call
4. Neogen reports year end results
5. Neogen Corporation Announces Year-End Results Conference Call
6. Neogen acquires Igenity from Merial
7. Neogen launches the fastest molecular pathogen test
8. Neogen Launches Fully Quantitative Lateral Flow Test for DON
9. Neogen Reports Second Quarter Results
10. Neogen Corporation Announces 2nd Quarter Results Conference Call
11. Elsevier Launches PracticeUpdate, a Free Information Portal for Physicians
Post Your Comments:
(Date:11/25/2015)... , November 26, 2015 ... Global Biobanking Market 2016 - 2020 report analyzes ... maintaining integrity and quality in long-term samples, minimizing ... long-term cost-effectiveness. Automation minimizes manual errors such as ... technical efficiency. Further, it plays a vital role ...
(Date:11/25/2015)... BRUSSELS , November 25, 2015 ... in cat and human plaque and pave the way for ... health problems in cats     ... the most commonly diagnosed health problems in cats, yet relatively ... until now. Two collaborative studies have been conducted by researchers ...
(Date:11/25/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: ... prospects remain fundamentally strong and highlights the following ... received DSMB recommendation to continue the ZoptEC Phase ... the final interim efficacy and safety data ... men with heavily pretreated castration- and Taxane-resistant prostate ...
(Date:11/25/2015)... November 25, 2015 The ... is a professional and in-depth study on the ...      (Logo: ) , ... industry including definitions, classifications, applications and industry chain ... the international markets including development trends, competitive landscape ...
Breaking Biology Technology:
(Date:11/11/2015)... MINNETONKA, Minn. , Nov. 11, 2015   MedNet ... the entire spectrum of clinical research, is pleased to announce ... Partnerships in Clinical Trials (PCT) event, to be held ... will be able to view live demonstrations of ... platform, and learn how iMedNet has been able ...
(Date:11/9/2015)... 09, 2015 ... the "Global Law Enforcement Biometrics Market ... --> ) has announced the ... Biometrics Market 2015-2019" report to their ... ( ) has announced the addition ...
(Date:11/2/2015)... 2, 2015  SRI International has been awarded a ... development services to the National Cancer Institute (NCI) PREVENT ... scientific expertise, modern testing and support facilities, and analytical ... and toxicology studies to evaluate potential cancer prevention drugs. ... PREVENT Cancer Drug Development Program is an NCI-supported pipeline ...
Breaking Biology News(10 mins):